Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

10 Sep 2021 15:25

RNS Number : 4581L
British Smaller Companies VCT2 Plc
10 September 2021
 

British Smaller Companies VCT2 plc

Unaudited Interim Results and Interim Management Report

for the six months ended 30 June 2021

 

British Smaller Companies VCT2 plc (the "Company") today announces its unaudited interim results for the six months ended 30 June 2021.

HIGHLIGHTS

· As announced on 27 August 2021 Total Return increased by 10.0p to 135.0p per share

· 18.2 per cent return on opening net assets

· Offer for Subscription fully subscribed raising £6.8 million

· Two new investments and five follow-on investments totalling £4.3 million were completed during the period

· 36.3 per cent overall growth in the investment portfolio value

· Subsequent to 30 June 2021, the Company realised its investment in Deep-Secure at the value held at 30 June 2021, generating capital proceeds of £3.3 million. The total return (including income) from this investment was £3.8 million, a multiple of 7.7x cost

· Net Asset Value at 30 June 2021 of 63.5p per share (31 December 2020: 55.0p)

· The Board is declaring a second interim dividend of 1.5p per share in respect of the year ending 31 December 2021, which, following the dividend of 1.5p per share paid on 5 March 2021, will bring total dividends paid in the current financial year to 3.0p per share

CHAIRMAN'S STATEMENT

In my previous Chairman's Statement for the year ended December 2020 I reported that, despite the trading conditions experienced throughout 2020, your Company's portfolio had proved resilient which was particularly reflected in a strong second half performance which had seen 16.7 per cent growth in the latter part of the year. I am pleased to report that, despite a further national lockdown in the first quarter of 2021, this has been continued in the six months to 30 June 2021. This has resulted in a further increase, after taking account of all costs, of 10.0 pence per share in Total Return, representing a return of 18.2 per cent of the opening Net Asset Value.

 

This continuing performance has seen a number of the investments seeking to extend or accelerate their growth plans which has resulted in further investment of £2.3 million into five of the portfolio businesses in the period. At the same time your Company has also added two further investments totalling £2.0 million.

 

During the period your Company successfully completed a small fundraising of £6.8 million which was raised over a 4 week period.

 

It is pleasing to report that, since the end of the period, your Company achieved the significant divestment of its investment in Deep Secure. This exit, which was realised at the value held at 30 June 2021, generated capital proceeds of £3.3 million delivering a realised gain of £2.8 million above cost, and an uplift of £1.3 million on the carrying value at the beginning of the year. Including income, the total return from this investment was £3.8 million over an 11.6 year holding period, producing an internal rate of return of 23 per cent and a multiple of 7.7x cost.

In addition, the Company has exchanged contracts for the realisation of 20 per cent of its investment in Matillion as part of its Series E funding round, which is expected to complete no later than 30 September 2021. As at 30 June 2021 the investment in Matillion was held at a value of £27.1 million. The proceeds from this partial exit are estimated at £6.0 million which is 3.4x the total cost of your Company's investment. The impact following this exchange of contracts is an additional increase on the 30 June 2021 net asset value of 1.4 pence per ordinary share (equivalent to 2.2 per cent).

 

Financial Results

Your Company's portfolio delivered a strong performance over the period, generating a return of £17.8 million, of which £0.1 million was realised and £17.7 million unrealised, of which Matillion was £14.4 million and Deep Secure was £1.3 million.

 

This represents an 18.2 per cent increase in Total Return since the start of the year and takes the Total Return above the hurdle at which a performance incentive becomes payable, provided that the Total Return is maintained through to 31 December 2021. As a result the Company has taken into account £3.3 million for a performance incentive with all returns stated after the provision.

 

The movement in net asset value ("NAV") per ordinary share and the dividends paid are set out in the table below:

 

Pence per ordinary share

£000

NAV at 31 December 2020

55.0

70,929

Increase in portfolio value

12.8

17,741

Gain on disposal of investments

-

105

Gain arising from investment portfolio

12.8

17,846

Incentive fee

(2.4)

(3,316)

Net operating costs

(0.4)

(525)

Issue/buy-back of new shares

-

6,041

Total Return in period

18.2%

10.0

20,046

NAV before the payment of dividends

65.0

90,975

Dividends paid

(1.5)

(1,934)

NAV at 30 June 2021

63.5

89,041

Cumulative dividends paid

71.5

Total Return:

At 30 June 2021

135.0

At 31 December 2020

125.0

 

Investments made since the changes to the VCT rules in November 2015 now comprise £52.6 million (74 per cent, cost of £29.2 million) of the unquoted portfolio as at 30 June 2021, with £18.6 million (26 per cent, cost of £14.8 million) of investments made prior to the rule changes. In general, the more recent additions to the portfolio are re-investing their profits for growth, with those investments comprising mainly equity instruments.

 

Dividends

An interim dividend of 1.5 pence per ordinary share in respect of the year ending 31 December 2021 was paid on 5 March 2021, bringing the cumulative dividends paid to date to 71.5 pence per ordinary share.

Your Board has proposed a second interim dividend of 1.5 pence per ordinary share for the year ending 31 December 2021 which, when combined with the above dividend paid in the period will bring total dividends paid in the current financial year to 3.0 pence per ordinary share (2020: 3.5 pence per ordinary share). The interim dividend will be paid on 25 October 2021 to shareholders on the register on 24 September 2021.

 

Shareholder Relations

As part of the Board's continuing communication with shareholders the Company held an on-line Investor Workshop on 25 June 2021 in conjunction with British Smaller Companies VCT plc. The webinar, which was attended by almost 200 shareholders, included presentations from Elucidat and Force24 along with presentations by members of the Manager.

 

Documents such as the annual report are now received by a large number of shareholders (83 per cent) via the website, www.bscfunds.com, rather than by post, which helps to meet the Board's Impact objectives and reduces printing costs. Your Board continues to encourage all shareholders to take up this option.

 

Your Company's website www.bscfunds.com, is refreshed on a regular basis and provides a comprehensive level of information in what I hope is a user-friendly format.

 

Regulatory Developments

Although the UK now has a new "state-aid" regime in place there have been no changes that impact your Company and the Manager continues to monitor for any changes.

 

Most new investments are now self-assured on a case-by-case basis and always with confirmation from professional advisers that they are Qualifying Investments. Advance assurance is sought where there is an element of uncertainty over the application of the rules.

 

Fundraising

As I have previously reported your Board has reviewed its fundraising plans and has concluded that it will shortly be launching a joint offer with British Smaller Companies VCT plc to raise in aggregate up to £40 million, with an over-allotment facility of £20 million.

 

Outlook

With most portfolio businesses having come through the pandemic largely unscathed or with improved competitive positions, your Company has been increasingly supporting those that that are investing for accelerated growth.

 

As we come out of the pandemic the volume of opportunities to back innovative business models and management teams continues to be strong. The plans to add additional investment capacity are intended to ensure that your Company remains well funded to take advantage of the investment opportunities as they arise.

 

Peter Waller

Chairman

 

OBJECTIVES AND STRATEGY

The Company's objective is over the long-term to maximise Total Return and provide investors with an attractive tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Investment Policy

The investment strategy of the Company is to invest in UK businesses across a broad range of sectors that blends a mix of businesses operating in established and emerging industries that offer opportunities in the application and development of innovation in their products and services.

These investments will all meet the definition of a Qualifying Investment and be primarily in unquoted UK companies. It is anticipated that the majority of these businesses will be re-investing their profits for growth and the investments will comprise mainly equity investments.

The Company seeks to build a broad portfolio of investments in early stage companies focused on growth with the aim of spreading the maturity profiles and maximising return as well as ensuring compliance with the VCT guidelines in this regard.

Borrowing

The Company funds the investment programmes out of its own resources and has no borrowing facilities for this purpose.

 

Co-investment

British Smaller Companies VCT2 plc and British Smaller Companies VCT plc ("the VCTs") have in aggregate first choice of all investment opportunities meeting the VCT qualifying criteria that require up to £4.5 million of equity. Amounts above £4.5 million will be allocated one third to YFM's co-investment funds and two thirds to the VCTs. Where there are opportunities for the VCTs to co-invest with each other the basis for allocation is 40 per cent to the Company and 60 per cent to British Smaller Companies VCT plc. The Board of the Company has discretion as to whether or not to take up or, where British Smaller Companies VCT plc does not take up its allocation, increase its allocation in such co-investment opportunities.

Asset Mix

Pending investment in venture capital trust qualifying securities, surplus cash is primarily held in interest bearing instant access, short-notice bank accounts, money market funds and investment funds listed on a recognised stock exchange (including FCA authorised and regulated UCITS funds). Subsequent to the Finance (No. 2) Act 2015 investments can no longer be made in non-qualifying quoted investments traded on an unregulated exchange. This change therefore now excludes most AIM investments in this category.

 

INVESTMENTREVIEW

The Company's portfolio at 30 June 2021 had a value of £71.16 million. Investments made since the VCT rule changes in 2015 comprised £52.61 million (74 per cent of the total value of the portfolio). The largest single investment represents 30.4 per cent of the net asset value.

Your Company's portfolio delivered a strong performance over the period, generating a return of £17.85 million of which £0.11 million was realised and £17.74 million unrealised. £14.38 million of this increase came from the investment in Matillion, with a further £1.31 million from Deep Secure.

There were also strong performances from Force24, Elucidat, Tonkotsu and Frescobol, offset by more difficult trading conditions at ACC Aviation, Arcus Global and Arraco.

Realisation of Investments

In the period the final deferred proceeds were recognised from the prior exit of three investments and further details of these realisations can be found in note 6. As noted previously the Company's investment in Deep Secure was realised at its 30 June 2021 valuation shortly after the period end at a substantial profit on its original cost and in August 2021 the Company exchanged contracts for the realisation of 20 per cent of its holding in Matillion.

Investments

During the six months ended 30 June 2021 the Company completed seven investments totalling £4.31 million. This comprised two new investments of £2.00 million and five follow-on investments of £2.31 million. The analysis of these investments is shown below:

 

Company

Investments made £million

New

Follow-on

Total

Outpost

1.00

-

1.00

Vypr

1.00

-

1.00

Wooshii

-

1.00

1.00

SharpCloud

-

0.81

0.81

Sipsynergy

-

0.33

0.33

Ncam

-

0.09

0.09

Biz2Mobile

-

0.08

0.08

Invested in the period

2.00

2.31

4.31

The follow-on investments into Wooshii, Sipsynergy and Biz2Mobile are all in support of product extensions which either add to an existing product or widen the range of products offered. In the cases of SharpCloud and Ncam the funding is primarily to further accelerate sales growth.

In the cases of both the new investments, whilst some product development is envisaged the principal use of the funding is to expand sales activities, with Outpost and Vypr targeting overseas expansions, particularly into the US.

This is symptomatic of the trends we continue to see in both the portfolio and the new investment opportunities.

INVESTMENT PORTFOLIO

The top 10 investments had a combined value of £52.1 million, 73.2 per cent of the total portfolio.

 

Name of Company

Sector

First

investment

Current

cost

 

£000

 

 

Value at

30 June 2021

£000

 

Proceeds

to date

 

£000

Capital return to date

£000

Matillion Limited

Data & Analytics

Nov 16

1,778

27,078

-

27,078

Deep-Secure Ltd

Software

Dec 09

500

3,275

-

3,275

Intelligent Office UK (IO Outsourcing t/a Intelligent Office)

Business Services

May 14

1,956

3,057

-

3,057

Wooshii Limited

New Media

May 19

2,440

2,852

-

2,852

Springboard Research Holdings Limited

Data & Analytics

Oct 14

1,822

2,838

120

2,958

KeTech Enterprises Limited

Data & Analytics

Nov 15

1,500

2,748

500

3,248

Unbiased EC1 Limited

Software

Dec 19

1,964

2,685

-

2,685

SharpCloud Software Limited

Data & Analytics

Oct 19

2,271

2,671

-

2,671

Elucidat Ltd

Software

May 19

1,800

2,643

-

2,643

Force24 Ltd

Software

Nov 20

1,600

2,273

-

2,273

Total top 10 investments

17,631

52,120

620

52,740

Remaining portfolio

ACC Aviation Group Limited*

Business Services

Nov 14

145

2,218

1,233

3,451

Arcus Global Limited

Software

May 18

1,950

1,732

-

1,732

Ncam Technologies Limited

New Media

Mar 18

1,675

1,596

-

1,596

Displayplan Holdings Limited

New Media

Jan 12

70

1,575

820

2,395

Sipsynergy

(via Hosted Network Services Limited)

Software

Jun 16

1,636

1,453

-

1,453

Tonkotsu Limited

Retail & Brands

Jun 19

1,592

1,160

-

1,160

Vypr Validation Technologies Limited

Data & Analytics

Jan 21

1,000

1,121

-

1,121

Arraco Global Markets Limited

Business Services

Dec 20

1,500

1,118

-

1,118

Outpost VFX Limited

New Media

Feb 21

1,000

1,118

-

1,118

Frescobol Carioca Ltd

Retail & Brands

Mar 19

1,200

864

-

864

Traveltek Group Holdings Limited

Software

Oct 16

1,163

756

-

756

Panintelligence (via Paninsight Limited)

Data & Analytics

Nov 19

1,000

750

-

750

e2E Engineering Limited

Business Services

Sept 17

600

529

-

529

£0.5 million and below

Other investments

11,876

3,052

5,400

8,452

Total portfolio

44,038

71,162

8,073

79,235

Full disposals to date

35,937

-

52,106

52,106

Total portfolio 

79,975

71,162

60,179

131,341

 

* Additional ordinary dividends of £1.93 million have also been received.

OUR PORTFOLIO AT A GLANCE

The charts on pages 12 and 13 of the interim report illustrate the broad range of the investment portfolio.

PRINCIPAL RISKS AND UNCERTAINTIES

In accordance with DTR 4.2.7, the Board confirms that the principal risks and uncertainties facing the Company have not materially changed from those identified in the Annual Report and Accounts for the year ended 31 December 2020. The Board acknowledges that there is regulatory risk and continues to manage the Company's affairs in such a manner as to comply with section 274 of the Income Tax Act 2007.

In summary, the principal risks are:

• Loss of approval as a Venture Capital Trust;

• Economic;

• Investment and strategic;

• Regulatory;

• Reputational;

• Operational;

• Financial; and

• Market/liquidity.

Full details of the principal risks can be found in the financial statements for the year ended 31 December 2020 on pages 32 to 34, a copy of which is available at www.bscfunds.com.

DIRECTORS' RESPONSIBILITIES STATEMENT

The directors of British Smaller Companies VCT2 plc confirm that, to the best of their knowledge, the condensed set of financial statements in this interim report have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" as adopted by the UK, and give a true and fair view of the assets, liabilities, financial position and profit and loss of British Smaller Companies VCT2 plc, and that the interim management report includes a true and fair review of the information required by DTR 4.2.7R and DTR 4.2.8R.

The directors of British Smaller Companies VCT2 plc are listed in note 11.

By order of the Board

 

Peter Waller

Chairman

 

UNAUDITED STATEMENT OF COMPREHENSIVE INCOME

for the six months ended 30 June 2021

 

Unaudited 6 months ended

30 June 2021

Unaudited 6 months ended

30 June 2020

Notes

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

Gains (losses) on investments held at fair value

6

-

17,741

17,741

-

(7,189)

(7,189)

Gains on disposal of investments

6

-

105

105

-

1,567

1,567

-

17,846

17,846

-

(5,622)

(5,622)

Income

2

337

-

337

450

-

450

Total income

337

17,846

18,183

450

(5,622)

(5,172)

Administrative expenses:

Manager's fee

(163)

(491)

(654)

(163)

(491)

(654)

Incentive fee

7

-

(3,316)

(3,316)

-

-

-

Other expenses

(208)

-

(208)

(228)

-

(228)

Fair value movement related to credit risk

-

-

-

(168)

-

(168)

(371)

(3,807)

(4,178)

(559)

(491)

(1,050)

(Loss) profit before taxation

(34)

14,039

14,005

(109)

(6,113)

(6,222)

Taxation

3

-

-

-

-

-

-

(Loss) profit for the period

(34)

14,039

14,005

(109)

(6,113)

(6,222)

Total comprehensive (expense) income for the period

(34)

14,039

14,005

(109)

(6,113)

(6,222)

Basic and diluted (loss) earnings per ordinary share

5

(0.02p)

10.28p

10.26p

(0.08p)

(4.69p)

(4.77p)

 

The Total column of this statement represents the Company's Unaudited Statement of Comprehensive Income, prepared in accordance with International Accounting Standards in conformity with the requirements of the Companies Act 2006 and those parts of the Companies Act 2006 applicable to companies reporting under IFRS. The supplementary Revenue and Capital columns are prepared under the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (issued in April 2021 - "SORP") published by the Association of Investment Companies.

UNAUDITED BALANCE SHEET

as at 30 June 2021

 

Notes

Unaudited

30 June

2021

 

Unaudited

30 June

2020

 

Audited

31 December

2020

 

£000

£000

£000

Assets

Non-current assets at fair value through profit and loss

Financial assets at fair value through profit or loss

6

71,162

37,065

49,115

Accrued income and other assets

545

326

444

71,707

37,391

49,559

Current assets

Accrued income and other assets

131

155

511

Cash on fixed term deposit

1,988

1,988

1,988

Cash and cash equivalents

18,613

23,209

19,002

20,732

25,352

21,501

Liabilities

Current liabilities

Trade and other payables

(82)

(98)

(131)

Provisions for liabilities and charges

7

(3,316)

-

-

Net current assets

17,334

25,254

21,370

Net assets

89,041

62,645

70,929

Shareholders' equity

Share capital

15,483

14,041

14,133

Share premium account

22,634

16,436

16,735

Capital redemption reserve

88

88

88

Other reserve

2

2

2

Merger reserve

5,525

5,525

5,525

Capital reserve

15,498

25,681

22,461

Investment holding gains and losses reserve

27,154

100

9,254

Revenue reserve

2,657

772

2,731

Total shareholders' equity

89,041

62,645

70,929

Net asset value per ordinary share

8

63.5p

48.4p

55.0p

 

 

Signed on behalf of the Board

 

Peter Waller

Chairman

 

UNAUDITED STATEMENT OF CHANGES IN EQUITY

for the six months ended 30 June 2021

 

Share

capital

Share

premium

account

Other

reserves*

Capital

reserve

Investment

holding

gains and

losses reserve

Revenue

reserve

Total

equity

£000

£000

£000

£000

£000

£000

£000

At 31 December 2019

14,041

16,436

5,615

25,223

9,948

1,070

72,333

Revenue return for the period

-

-

-

-

-

(109)

(109)

Expenses charged to capital

-

-

-

(491)

-

-

(491)

Investment holding loss on investments held at fair value

-

-

-

-

(7,189)

-

(7,189)

Realisation of investments in the period

-

-

-

1,567

-

-

1,567

Total comprehensive income (expense) for the period

-

-

-

1,076

(7,189)

(109)

(6,222)

Purchase of own shares

-

-

-

(868)

-

-

(868)

Dividends

-

-

-

(2,409)

-

(189)

(2,598)

Total transactions with owners

-

-

-

(3,277)

-

(189)

(3,466)

Realisation of prior year investment holding gains

-

-

-

2,659

(2,659)

-

-

At 30 June 2020

14,041

16,436

5,615

25,681

100

772

62,645

Revenue return for the period

-

-

-

-

-

1,979

1,979

Expenses charged to capital

-

-

-

(412)

-

-

(412)

Investment holding gain on investments held at fair value

-

-

-

-

8,804

-

8,804

Realisation of investments in the period

-

-

-

102

-

-

102

Total comprehensive (expense) income for the period

-

-

-

(310)

8,804

1,979

10,473

Issue of shares - DRIS

92

319

-

-

-

-

411

Issue costs of ordinary shares**

-

(20)

-

-

-

-

(20)

Purchase of own shares

-

-

-

(640)

-

-

(640)

Dividends

-

-

-

(1,920)

-

(20)

(1,940)

Total transactions with owners

92

299

-

(2,560)

-

(20)

(2,189)

Realisation of prior year investment holding losses

-

-

-

(350)

350

-

-

At 31 December 2020

14,133

16,735

5,615

22,461

9,254

2,731

70,929

Revenue return for the period

-

-

-

-

-

(34)

(34)

Expenses charged to capital

-

-

-

(3,807)

-

-

(3,807)

Investment holding gain on investments held at fair value

-

-

-

-

17,741

-

17,741

Realisation of investments in the period

-

-

-

105

-

-

105

Total comprehensive (expense) income for the period

-

-

-

(3,702)

17,741

(34)

14,005

Issue of share capital

1,276

5,772

-

-

-

-

7,048

Issue of shares - DRIS

74

324

-

-

-

-

398

Issue costs of ordinary shares**

-

(197)

-

(47)

-

-

(244)

Purchase of own shares

-

-

-

(1,161)

-

-

(1,161)

Dividends

-

-

-

(1,934)

-

-

(1,934)

Total transactions with owners

1,350

5,899

-

(3,142)

-

-

4,107

Realisation of prior year investment holding losses

-

-

-

(119)

159

(40)

-

At 30 June 2021

15,483

22,634

5,615

15,498

27,154

2,657

89,041

 

*Other reserves include the capital redemption reserve, the merger reserve and the other reserve, which are non-distributable.

**Issue costs include both fundraising costs (where applicable) and costs incurred from the Company's DRIS.

Reserves available for distribution

Under the Companies Act 2006 the capital reserve and the revenue reserve are distributable reserves.

The table below shows amounts that are available for distribution.

Capital reserve

£000

Revenue reserve

£000

Total

£000

 

Distributable reserves as above

15,498

2,657

18,155

Less: Income not yet distributable

-

(960)

(960)

: Revaluation losses

(1,400)

-

(1,400)

Reserves available for distribution*

14,098

1,697

15,795

* subject to filing these interim financial statements at Companies House.

The capital reserve and the revenue reserve are both distributable reserves. These reserves total £18,155,000, representing a decrease of £7,037,000 in the period since 31 December 2020. The directors also take into account the level of the investment holding gains and losses reserve and the future requirements of the Company when determining the level of dividend payments.

Of the potentially distributable reserves of £18,155,000 shown above, £960,000 relates to income not yet receivable. In addition, revaluation losses of £1,400,000 included within the investment holding gains and losses reserve are not considered to be recoverable.

 

UNAUDITED STATEMENT OF CASH FLOWS

for the six months ended 30 June 2021

Notes

Unaudited

6 months

ended

30 June

2021

Unaudited

6 months

ended

30 June

2020

Audited

year

ended

31 December

2020

£000

£000

£000

Profit (loss) before taxation

14,005

(6,222)

4,251

Increase in provisions for liabilities and charges

7

3,316

-

-

Decrease in trade and other payables

(49)

(68)

(35)

(Increase) decrease in accrued income and other assets

(87)

173

65

Gains on disposal of investments

(105)

(1,567)

(1,669)

(Gains) losses on investments held at fair value

(17,741)

7,189

(1,615)

Capitalised income

-

-

(59)

Net cash (outflow) inflow from operating activities

(661)

(495)

938

Cash flows from investing activities

Purchase of financial assets at fair value through profit or loss

6

(4,306)

(410)

(3,997)

Proceeds from sale of financial assets at fair value through profit or loss

6

-

5,636

5,772

Deferred consideration

6

471

-

-

Net cash (outflow) inflow from investing activities

(3,835)

5,226

1,775

Cash flows from financing activities

Issue of ordinary shares

7,048

-

-

Costs of ordinary share issues*

(244)

-

(20)

Purchase of own shares

(1,161)

(868)

(1,508)

Dividends paid

4

(1,536)

(2,598)

(4,127)

Net cash inflow (outflow) from financing activities

4,107

(3,466)

(5,655)

Net (decrease) increase in cash and cash equivalents

(389)

1,265

(2,942)

Cash and cash equivalents at the beginning of the period

19,002

21,944

21,944

Cash and cash equivalents at the end of the period

18,613

23,209

19,002

 

*Issue costs include both fundraising costs and expenses incurred from the Company's DRIS.

 

EXPLANATORY NOTES TO THE UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

1 General Information, Basis of Preparation and Principal Accounting Policies

These half-yearly statements have been approved by the directors whose names appear at note 11, each of whom has confirmed that to the best of their knowledge:

• the interim management report includes a fair review of the information required by rules 4.2.7 and 4.2.8 of the Disclosure Rules and the Transparency Rules; and

• the half-yearly statements have been prepared in accordance with IAS 34 'Interim financial reporting' and the Disclosure and Transparency Rules of the Financial Conduct Authority.

The half-yearly statements are unaudited but have been reviewed by the auditors pursuant to the International Standard on Review Engagements (UK and Ireland) 2410 guidance on Review of Interim Financial Information performed by the independent Auditor of the entity. They do not constitute full financial statements as defined in section 435 of the Companies Act 2006. The comparative figures for the year ended 31 December 2020 do not constitute full financial statements and have been extracted from the Company's financial statements for the year ended 31 December 2020. Those accounts were reported upon without qualification by the auditors and have been delivered to the Registrar of Companies.

The accounting policies and methods of computation followed in the half-yearly statements are the same as those adopted in the preparation of the audited financial statements for the year ended 31 December 2020. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the 2020 annual report.

The accounts have been prepared on a going concern basis in accordance with International Accounting Standards in conformity with the requirements of the Companies Act 2006 and those parts of the Companies Act 2006 applicable to companies reporting under IFRS. The accounts have been prepared in compliance with the recommendations set out in the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued by the Association of Investment Companies (issued in April 2021 - "SORP") to the extent that they do not conflict with International Accounting Standards in conformity with the Companies Act 2006.

The financial statements have been prepared under the historical cost basis as modified by the measurement of investments at fair value through profit or loss.

The financial statements are prepared in accordance with IFRSs and interpretations in force at the reporting date. New standards coming into force during the year have not had a material impact on these financial statements. The Company has carried out an assessment of accounting standards, amendments and interpretations that have been issued by the IASB and that are effective for the current reporting period. The Company has determined that the transitional effects of the standards do not have a material impact.

The financial statements are presented in sterling and all values are rounded to the nearest thousand (£000), except where stated.

Going Concern: The directors have carefully considered the issue of going concern and are satisfied that the Company has sufficient resources to meet its obligations as they fall due for a period of at least twelve months from the date these half-yearly statements were approved. As at 30 June 2021 the Company held cash balances and fixed term deposits with a combined value of £20,601,000. Cash flow projections show the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of share buy-backs and the dividend policy.

In the year ended 31 December 2020 the Company's costs and discretionary expenditures were:

£'000

Administrative expenses (before fair value movements related to credit risk)

1,663

Share buybacks

1,508

Dividends (before DRIS)

4,538

Total

7,709

The directors therefore believe that it is appropriate to continue to apply the going concern basis of accounting in preparing these half-yearly statements.

 

2 Income

Unaudited

6 months

ended

30 June

2021

£000

Unaudited

6 months

ended

30 June

2020

£000

Income from investments

- Dividends from unquoted companies

155

177

- Interest on loans to unquoted companies

152

187

Income from investments held at fair value through profit or loss

307

364

Interest on bank deposits

30

86

337

450

 

3 Taxation

Unaudited 6 months ended

30 June 2021

Unaudited 6 months ended

30 June 2020

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

(Loss) profit before taxation

(34)

14,039

14,005

(109)

(6,113)

(6,222)

(Loss) profit before taxation multiplied by the standard small company rate of corporation tax in UK of 19.0% (2020: 19.0%)

(6)

2,667

2,661

(21)

(1,161)

(1,182)

Effect of:

UK dividends received

(30)

-

(30)

(21)

-

(21)

Non-taxable profits on investments

-

(3,391)

(3,391)

-

1,068

1,068

Deferred tax not recognised

36

724

760

42

93

135

Tax charge

-

-

-

-

-

-

The Company has no provided, or unprovided, deferred tax liability in either period.

Deferred tax assets in respect of losses have not been recognised as the directors do not currently believe that it is probable that sufficient taxable profits will be available against which the assets can be recovered.

Due to the Company's status as a venture capital trust, and the continued intention to meet the conditions required to comply with Chapter 3 Part 6 of the Income Tax Act 2007, the Company has not provided deferred tax on any capital gains or losses arising on the revaluation or realisation of investments.

4 Dividends

Amounts recognised as distributions to equity holders in the period:

 

Unaudited

6 months ended

30 June 2021

Unaudited

6 months ended

30 June 2020

Audited

Year ended

31 December 2020

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

£000

£000

£000

Interim dividend for the year ending 31 December 2021 of 1.5p (2020: 2.0p) per ordinary share

-

1,934

1,934

189

2,409

2,598

189

2,409

2,598

Second interim dividend for the year ended 31 December 2020 of 1.5p per ordinary share

-

-

-

-

-

-

20

1,920

1,940

-

1,934

1,934

189

2,409

2,598

209

4,329

4,538

Shares allotted under DRIS

(398)

-

(411)

Dividends paid in the Statement of Cash Flows

1,536

2,598

4,127

 

The interim dividend of 1.5 pence per ordinary share was paid on 5 March 2021 to shareholders on the register as at 5 February 2021.

An interim dividend of 1.5 pence per ordinary share, amounting to approximately £2.1 million, is proposed. The dividend has not been recognised in these half-yearly financial statements as the obligation did not exist at the balance sheet date.

5 Basic and Diluted (Loss) Earnings per Ordinary Share

The basic and diluted earnings (loss) per ordinary share is based on the profit after tax attributable to equity shareholders of £14,005,000 (30 June 2020: loss of £6,222,000) and 136,437,520 (30 June 2020: 130,407,271) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted revenue loss per ordinary share is based on the revenue loss attributable to equity shareholders of £34,000 (30 June 2020: loss of £109,000) and 136,437,520 (30 June 2020: 130,407,271) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted capital earnings (loss) per ordinary share is based on the capital profit attributable to equity shareholders of £14,039,000 (30 June 2020: loss of £6,113,000) and 136,437,520 (30 June 2020: 130,407,271) ordinary shares being the weighted average number of ordinary shares in issue during the period.

During the period the Company allotted 12,756,951 new ordinary shares from the fundraising, and 742,805 new ordinary shares in respect of its DRIS.

The Company has also repurchased 2,224,798 of its own shares in the period and these shares are held in the capital reserve. The total of 14,601,235 treasury shares has been excluded in calculating the weighted average number of ordinary shares during the period.

The Company has no dilutive shares and consequently, basic and diluted earnings per ordinary share are equivalent at 30 June 2021, 31 December 2020 and 30 June 2020.

6 Financial Assets at Fair Value through Profit or Loss

IFRS 13 and IFRS 7, in respect of financial instruments that are measured in the balance sheet at fair value, require disclosure of fair value measurements by level within the following fair value measurement hierarchy:

Level 1: quoted prices in active markets for identical assets or liabilities. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is defined as a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. The quoted market price used for financial assets held by the Company is the current bid price. The Company does not currently hold any Level 1 investments.

Level 2: the fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2. The Company held no such instruments in the current or prior year.

Level 3: the fair value of financial instruments that are not traded in an active market (for example, investments in unquoted companies) is determined by using valuation techniques such as earnings or sales multiples. If one or more of the significant inputs is not based on observable market data, the instrument is included in Level 3. All of the Company's investments fall into this category.

Each investment is reviewed at least quarterly to ensure that it has not ceased to meet the criteria of the level in which it was included at the beginning of each accounting period. There have been no transfers between these classifications in the period (2020: none).

The change in fair value for the current and previous year is recognised through profit or loss. All items held at fair value through profit or loss were designated as such upon initial recognition.

Valuation of Investments

Unquoted investments are valued in accordance with IFRS 13 "Fair Value Measurement" and using the International Private Equity and Venture Capital ("IPEVC") Valuation Guidelines ("the Guidelines") issued in December 2018 and updated in March 2020.

Initial measurement

The best estimate of the initial fair value of an unquoted investment is the cost of the investment. Unless there are indications that this is inappropriate, an unquoted investment will be held at this value within the first three months of investment.

Subsequent measurement

Based on the Guidelines we have identified six of the most widely used valuation methodologies for unquoted investments. The Guidelines advocate that the best valuation methodologies are those that draw on external, objective market-based data in order to derive a fair value.

Full details of the methods used by the Company were set out on pages 66 and 67 of the financial statements for the year ended 31 December 2020, a copy of which can be found at www.bscfunds.com.

The primary methods used for valuing non-quoted investments, and the key assumptions relating to them are:

Unquoted Investments

· revenue multiple. An appropriate multiple, given the risk profile and revenue growth prospects of the underlying company, is applied to the revenue of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

· earnings multiple. An appropriate multiple, given the risk profile and earnings growth prospects of the underlying company, is applied to the maintainable earnings of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

Movements in investments at fair value through profit or loss during the six months to 30 June 2021 are summarised as follows:

IFRS 13 measurement classification

Level 3

Unquoted

Investments

 

 

£000

Opening cost

39,891

Opening valuation gain

9,224

Opening fair value at 1 January 2021

49,115

Additions at cost

4,306

Change in fair value

17,741

Closing fair value at 30 June 2021

71,162

Closing cost

44,038

Closing valuation gain

27,124

Closing fair value at 30 June 2021

71,162

The profit on disposal shown in the Statement of Comprehensive Income is £105,000. This represents the change in the value of deferred proceeds in respect of assets which have been disposed of and are not included within the investment portfolio at 1 January 2021.

Level 3 valuations include assumptions based on non-observable data, such as discounts applied either to reflect changes in fair value of financial assets held at the price of recent investment, or to adjust earnings multiples.

IFRS13 requires disclosure, by class of financial instruments, if the effect of changing one or more inputs to reasonably possible alternative assumptions would result in a significant change to fair value measurement. Each unquoted portfolio company has been reviewed and both downside and upside alternative assumptions have been identified and applied to the valuation of each of the unquoted investments. Applying the downside alternative the value of the unquoted investments would be £2,665,000 (3.7 per cent) lower. Using the upside alternative the value would be increased by £3,885,000 (5.5 per cent).

All the Company's investments are in unquoted companies held at fair value. The valuation methodology for these investments includes the application of externally produced revenue and earnings multiples. Therefore the value of the unquoted element of the portfolio is also indirectly affected by price movements on the listed market. Those using earnings and revenue multiple methodologies include judgements regarding the level of discount applied to that multiple. A 10 per cent decrease in the discount applied would have increased the net assets attributable to the Company's shareholders and the total profit by £3,546,000 (4.0 per cent of net assets). An equal change in the opposite direction would have decreased net assets attributable to the Company's shareholders and the total profit by £3,726,000 (4.2 per cent of net assets).

There have been no individual fair value adjustments downwards during the period that exceeded 5 per cent of the total assets of the Company (31 December 2020: none).

The following disposals took place during the period.

 

Net

proceeds

from sale

 

Cost

 

Opening

carrying

value as at

1 January

2021

Gain

over

opening

carrying

value

£000

£000

£000

£000

Unquoted investments

Macro Art Holdings Limited

-

159

-

-

Total from unquoted investments

-

159

-

-

Deferred proceeds

Bagel Nash Group Limited

100

-

66

34

Business Collaborator Limited

300

-

300

-

Ness (Holdings) Limited

71

-

-

71

Deferred proceeds received

471

-

366

105

Total

471

159

366

105

7 Provisions for Liabilities and Charges

Incentive Fee

Under the terms of the Subscription Rights Agreement, the Manager and Chord Capital are entitled to a performance-related incentive fee if the cumulative dividends per ordinary share paid as at the last business day of December in any year, plus the average of the middle market price per ordinary share of the five dealing days prior to that day, exceeds a Hurdle of 120 pence per ordinary share. The value of the incentive fee is 20 per cent of the excess to the Hurdle, multiplied by the number of ordinary shares issued. There has never been an incentive fee payment under this scheme and there was no payment for the year to 31 December 2020, as the shortfall to the Hurdle was 1.8 pence per ordinary share. However, excluding the payment of dividends, the net assets per ordinary share have increased by 10.0 pence per ordinary share as at 30 June 2021. If this increase flows through to an increase in the middle market price per ordinary share in the last five dealing days prior to the last business day of December 2021, at a discount of 5 per cent to the net asset value per ordinary share, then an incentive fee of approximately £3,316,000 would be payable at 31 December 2021 based on the number of shares in issue at 30 June 2021.

8 Basic and Diluted Net Asset Value per Ordinary Share

The basic and diluted net asset value per ordinary share is calculated on attributable assets of £89,041,000 (30 June 2020 and 31 December 2020: £62,645,000 and £70,929,000 respectively) and 140,231,049 (30 June 2020 and 31 December 2020: 129,373,784 and 128,956,091 respectively) ordinary shares in issue at 30 June 2021.

The 14,601,235 (30 June 2020 and 31 December 2020: 11,035,854 and 12,376,437 respectively) treasury shares have been excluded in calculating the number of ordinary shares in issue at 30 June 2021.

The Company has no potentially dilutive shares and consequently, basic and diluted net asset values are equivalent at 30 June 2021, 31 December 2020 and 30 June 2020.

9 Total Return

Total Return per ordinary share is calculated on cumulative dividends paid of 71.5 pence per ordinary share (30 June 2020: 68.5 pence per ordinary share and 31 December 2020: 70.0 pence per ordinary share) plus the net asset value as calculated in note 8.

10 Post Balance Sheet Events

The Company's investment in Deep Secure was realised at its 30 June 2021 valuation shortly after the period end at a substantial profit on its original cost. In addition, the Company has exchanged contracts for the realisation of 20 per cent of its investment in Matillion as part of its Series E funding round, which is expected to complete no later than 30 September 2021. As at 30 June 2021 the investment in Matillion was held at a value of £27.1 million. The proceeds from this partial exit are estimated at £6.0 million which is 3.4x the total cost of your Company's investment.

11 Directors

The directors of the Company are: Peter C Waller, Barbara L Anderson, and Roger S McDowell.

12 Other Information

Copies of the interim report can be obtained from the Company's registered office: 5th Floor, Valiant Building, 14 South Parade, Leeds, LS1 5QS or from www.bscfunds.com.

 

13 Interim Dividend for the year ending 31 December 2021

The directors are pleased to announce the payment of a second interim dividend for the year ending 31 December 2021 of 1.5 pence per ordinary share ("Interim Dividend").

The Interim Dividend will be paid on 25 October 2021 to those shareholders on the Company's register at the close of business on 24 September 2021. The ex-dividend date will be 23 September 2021.

 

14 Dividend Re-investment Scheme

The Company operates a dividend re-investment scheme ("DRIS"). The latest date for receipt of DRIS elections so as to participate in the DRIS in respect of the Interim Dividend is the close of business on 8 October 2021.

 

15 Inside Information

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

For further information, please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR ZBLFFFKLLBBL
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.